ByteDance’s AI drug unit Anew Labs raises $290M at $1.5B valuation, Reuters reports
This story is from 2026-09-16. It is preserved in the archive; the latest stories are on the live feed.
ByteDance closed a $290M funding round for Anew Labs, its newly spun-off AI drug discovery unit, at a $1.5B valuation, Reuters reports, citing two sources familiar with the matter. Moreover, the company that owns TikTok will retain 56% of the business after this round, according to the same sources…
Read the full story at The Next Web ↗
Timeline · 1 report
- 2026-09-16 08:10 · The Next Web
ByteDance’s AI drug unit Anew Labs raises $290M at $1.5B valuation, Reuters reports